Active Ingredient History

  • Now
Teplizumab is a humanized anti-CD3 monoclonal antibody that is being evaluated for treatment and prevention of type 1 diabetes mellitus (T1DM) by the biopharmaceutical company Provention Bio. Teplizumab has also been evaluated for treatment of renal allograft rejection, for induction therapy in islet transplant recipients, and for psoriatic arthritis.   Wikipedia

More Chemistry
anti-cd3 monoclonal antibody | hokt3gamma1 | hokt3 gamma 1 (ala-ala) | hokt3gamma1 (ala-ala) | hokt3gamma1(ala-ala) | hokt3γ1 | humanized okt3 gamma1(ala-ala) | humanized okt3gamma1(ala-ala) | humanzied okt3 | mga031 | okt3gamma1 ala-ala, humanized | teplizumab


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue